Országos Gyógyszerészeti Intézet

Contact points About us Links F.A.Q. Events Contact Sightless version RSS Magyar

News Supervision » Inspection GMP Inspections GLP Inspections GCP Inspections GDP Inspections Pharmacovigilance Inspection Pharmacovigilance Pharmacovigilance reporting requirements Information for healthcare professionals and consumers Information for marketing authorization holders SPC and PIL wordings of the PhVWP Counterfeit medicines Advertisement control Methodology » Pharmaceutical methodology NIP medicine reviewers Pharmacopoeia Hungarica VIII Formulae Normales VII Drug information » Drug database Lists Paramedicines Expiry date extension Temporary discontinuation of sale Rapid Alert Withdrawal from the market Laws and regulations Finance Forms	news 2012.01.26 - Updated information on the pharmacovigilance obligations imposed on the MAH 2011.11.28 - Information on National Scope Variations has changed: New information about MAH-transfer procedures 2011.08.31 - Changes regardig adverse reaction reporting arising from clinical trials 2011.06.07 - National Institute for Quality- and Organizational Development in Healthcare and Medicines 2011.03.04 - Important information about payment for maintenance of the marketing authorisation Last updated: 2008.08.25 09:37 printer version
National Institute for Quality- and Organizational Development in Healthcare and Medicines National Institute of Pharmacy \| H-1051 Budapest, Zrínyi u. 3. \| Mail: 1372 P.O. Box: 450. Tel: +36 1 88 69 -300 \| Fax: +36 1 88 69-460 \| Contact \| Impressum \| Sitemap \| Copyright Opening hours for docketing: Monday to Thursday: 8.30-12.00, Friday: 8.30-11.00